Munich - Delayed Quote EUR
Vertex Pharmaceuticals Inc (VX1.MU)
439.25
-3.65
(-0.82%)
At close: May 2 at 5:25:00 PM GMT+2
Loading Chart for VX1.MU
- Previous Close
442.90 - Open
444.00 - Bid 442.25 x --
- Ask 444.05 x --
- Day's Range
439.25 - 444.00 - 52 Week Range
373.05 - 483.05 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: VX1.MU
View MorePerformance Overview: VX1.MU
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
VX1.MU
13.65%
S&P 500 (^GSPC)
3.31%
1-Year Return
VX1.MU
17.48%
S&P 500 (^GSPC)
12.29%
3-Year Return
VX1.MU
68.97%
S&P 500 (^GSPC)
36.85%
5-Year Return
VX1.MU
83.02%
S&P 500 (^GSPC)
100.89%
Compare To: VX1.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VX1.MU
View MoreValuation Measures
As of 5/2/2025
Market Cap
114.06B
Enterprise Value
110.19B
Trailing P/E
--
Forward P/E
28.17
PEG Ratio (5yr expected)
1.36
Price/Sales (ttm)
11.64
Price/Book (mrq)
7.79
Enterprise Value/Revenue
11.29
Enterprise Value/EBITDA
255.95
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--